Abstract
Selective plasma exchange has been shown to be effective in various diseases, but no studies have assessed the benefits of daily treatment. We aimed to investigate the removal dynamics of immunoglobulins, fibrinogen, and factor XIII on three consecutive days in three patients. For mean processed plasma volumes of 1.06 × plasma volume, reductions of 79.6%, 49.3%, and 8.6% were seen for immunoglobulins G, A, and M, respectively. The reductions for fibrinogen and factor XIII were 18.4% and 13.0%, respectively. Removal dynamics were similar for immunoglobulin G-related autoantibodies and immunoglobulin G when using daily selective plasma exchange. Moreover, daily use effectively removed the immunoglobulin G while retaining the coagulation factors. When disease-specific autoantibodies are limited to immunoglobulin G, daily selective plasma exchange may be a useful and safe method of intensive induction treatment for plasmapheresis. However, further study is required in larger cohorts to confirm these findings.
References
May 1, 1993·Critical Care Medicine·J BougetJ C Raphael
Apr 16, 1999·Transfusion·B C McLeodJ W Smith
Oct 28, 1999·Acta Neurologica Scandinavica·J H Yeh, H C Chiu
Dec 18, 2001·Journal of Clinical Apheresis·J H Yeh, H C Chiu
Jul 5, 2005·Lancet·Jean-Claude Bystryn, Jennifer L Rudolph
Jul 16, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ying GaoMing-Hui Zhao
Aug 19, 2007·Journal of Neurology·Isha TrikhaMadhuri Behari
Jun 20, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andre A Kaplan
Oct 15, 2008·Lancet Neurology·Josep DalmauDavid R Lynch
Jun 17, 2009·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Mariko SeishimaTakahiko Aoki
Oct 7, 2011·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Norio Hanafusa
Feb 20, 2013·Journal of Clinical Apheresis·Andre A Kaplan
Jun 27, 2014·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Atsushi OhkuboTatemitsu Rai
Aug 19, 2014·Vox Sanguinis·J KoesslerE Klinker
Sep 20, 2015·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Atsushi OhkuboTatemitsu Rai
Aug 16, 2016·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Hajime NakaeToshiko Igarashi
Aug 16, 2016·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Satoko MiyamotoTomokazu Okado
Oct 7, 2016·Journal of Clinical Apheresis·Kahori NasuMasaomi Nangaku
May 17, 2017·CEN Case Reports·Mayuko KawabeTakashi Yokoo
Jul 1, 2017·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Satoko MiyamotoTomokazu Okado
Sep 25, 2017·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Atsushi Ohkubo, Tomokazu Okado
Jan 16, 2018·Clinical and Experimental Dermatology·J JankáskováM Sárdy